The difference in Ki-67 expression between patients who progressed to neoplasia and those who experienced remission of the disease was not significant, which can be attributed to the fact that the authors had fewer participants who progressed to neoplasia than did other studies that included larger samples.12 This evidence concerns the gene MKI67 and neoplasm.